Goldman Sachs Asset Management, which manages over $2 trillion in assets, is looking to buy tech and small-cap stocks following the U.S. equities selloff and amid an expected normalization in rates. Details “What we’re looking at now is: can we buy some select tech names and the small-caps space,” said…
Shares of hearing implant developer Envoy Medical surged almost 20% on Monday, August 12. Before the market opened, the company reported its second-quarter 2024 results and announced that, after 18 months of preliminary research on its cochlear implant — which essentially replaces the function of the inner ear — it…
Sonoma Pharmaceuticals, which develops treatments for dermatological conditions and advanced wound care with its flagship product stabilized hypochlorous acid, saw its stock plunge almost 20% on Friday, August 9. The losses followed the release of worse than expected quarterly financial results. Details Sonoma stock fell 19.7% on Friday to $0.25…
Shares of VolitionRx, a company that develops early-detection tests for serious diseases, fell over 7% on Friday, August 9. This came after the company announced a direct offering in which it plans to sell up to $21.5 million of new shares and warrants to an undisclosed investor. Details VolitionRx stock…
Innodata, a U.S. provider of IT services and enterprise software, saw its stock surge more than 21% in premarket trading on Friday, August 9. The gains followed the announcement of record revenue growth of 66% in the second quarter, as well as upgraded guidance for the year. Details On Friday,…
Shares of Viemed Healthcare, a company that provides in-home respiratory support and has a market capitalization of $278.7 million, rose nearly 10% on Thursday, August 8. The day before, the company reported upbeat earnings for the second quarter of 2024: net revenue had its best quarterly performance ever, having risen…
Citius Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved its lymphoma drug LYMPHIR. This marks the first FDA approval for the drug developer. Despite this, quotes on Citius Pharmaceuticals shares plummeted 17% after the opening bell, followed by a slight rebound later. Earlier this week, Citius…
On Wednesday, August 7, Canada’s KITS Eyecare, a retailer of eyewear and contact lenses, reported that its revenue grew 26% to a record CAD37.9 million (approximately $27.6 million) in the second quarter of 2024. Quotes on KITS shares closed 5% higher on the Toronto Stock Exchange. Details The company’s revenue…
“A caravan of combine harvesters chew up the grassland under the open prairie sky. They hum along in staggered rows, on the way to fill up grain elevators in the distance. The air smells like a combination of a bakery, brewery, and grassland,” Lionel Kambeitz, cofounder of Canada’s Above Food,…
The explosive growth of the AI market has taken many tech stocks to record highs, but the Motley Fool argues that there are still hidden gems out there, highlighting three companies in particular: processor manufacturer AMD, cybersecurity company SentinelOne, and IT service provider Innodata. Each of them, though differing in…
Shares of the biotechnology company Equillium, with a market capitalization of $25.7 million, surged over 15% on Tuesday, August 6. The trigger was positive interim results from the trial of its drug for graft-versus-host disease (GvHD), a condition in which a donor’s immune cells attack a recipient’s body, recognizing it…
Nonlethal weapons manufacturer Byrna Technologies may repurchase up to $10 million of its stock under a new buyback program. At the start of trading on Monday, August 5, quotes on Byrna were on the rise but eventually ended the session down 2%. Details In the report filed with the U.S.…
Citius Pharmaceuticals, a developer of drugs for bloodstream infections, lymphoma, and hemorrhoids, is one step closer to spinning off its oncology business as a separate Nasdaq-listed company. On Monday, August 5, shares of Citius Pharma rose nearly 3% on the news, despite a broader market selloff. Details Citius Pharma, with…
On Friday, August 2, IES Holdings, which designs and installs integrated electrical and technology systems for a variety of end markets, released its results for the fiscal-2024 third quarter (ended June 30) and announced that the board of directors had approved a new $200 million stock buyback program. This announcement,…
Quotes on shares of Inuvo, a provider of AI-driven advertising technology, rose almost 3.5% on Thursday, August 1, following the announcement of a new $10 million credit line. Details Inuvo stock added 3.45% to $0.32 per share during trading in New York on Thursday. It has lost 26% so far…
Simply Wall St sees the stock of Crexendo, a provider of cloud platforms and services for businesses, as undervalued, believing it should be trading 50% higher. Details Simply Wall St analysts put the fair value of Crexendo at $6.28 per share, 53% higher than the closing price on Thursday, August…
Canada’s KITS Eyecare sells eyewear online. It wants people to own multiple pairs of glasses, similar to how they have many scarves and headscarves. The advantage of the business is its special online vision test technology and its own production facilities, allowing it to keep prices low and quickly deliver…
The first vaping addiction treatment, developed by Achieve Life Sciences, has been designated a “breakthrough therapy” by regulators, the company reported. This status means the company can get the product to market faster and skip the last phase of clinical trials. Achieve’s stock gained on the news. Details The U.S.…
Quotes on shares of Envoy Medical, a developer of fully implanted hearing systems, jumped 14.5% on Wednesday, July 31. Buoying the stock was news of a U.S. Senate bill that, if passed, would make the company’s implants eligible for insurance coverage, the company reported. According to Envoy Medical, nearly 40…
In July, the Russell 2000 small-cap index has outpaced the tech-heavy Nasdaq Composite by 12.7 percentage points, according to Dow Jones Market Data cited by the Wall Street Journal. If this trend holds until the end of the trading day today, the last day of the month, it will mark…
Quotes on shares of CNS Pharmaceuticals, a developer of drugs to treat brain and central nervous system cancers, plummeted more than 60% on Tuesday, July 30. This came after an agreement was announced with Cortice Biosciences that gives CNS Pharma the intellectual property rights to a brain cancer treatment molecule…
Barron’s has published a Morningstar-compiled list of the most popular stocks with small-cap funds. The past month has been great for small-cap stocks, the publication notes, but navigating them can be quite challenging given the lack of media attention and Wall Street analyst coverage. Barron’s sought to find out what…
Shares of La Rosa Holdings, a provider of real estate brokerage and related services, plunged almost 12% in trading on Monday, July 29. This came after the company announced that, with the consent of the majority shareholder, it had sold a promissory note worth around $0.5 million, along with shares…
Quotes on shares of Above Food, a regenerative agriculture company, plummeted following a corporate update for investors. The company acknowledged that it lacked working capital for growing its business in the 2024 fiscal year (ended January 31, 2024). As a result, revenue for the full year was lower than 2023,…
